← Back to Search

Antimicrobial Agent

Antimicrobial Wound Gel for Surgical Site Complications

N/A
Waitlist Available
Led By Giles Scuderi
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scheduled to undergo primary hip or knee arthroplasty
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 12 weeks of the index procedure
Awards & highlights

Study Summary

This trial will study whether a new wound treatment can reduce surgical site complications and improve post-operative treatment outcomes.

Who is the study for?
This trial is for adults over 18 who are scheduled for primary hip or knee replacement surgery and can consent to participate. They must be able to follow the study's procedures throughout its duration. People with allergies to any study products, mental impairments preventing proper consent, or those considered vulnerable under specific federal regulations cannot join.Check my eligibility
What is being tested?
The trial is testing SurgX Antimicrobial Wound Gel against standard wound care in patients undergoing hip or knee replacements. The goal is to see if SurgX reduces complications and improves outcomes by targeting bacteria at the surgical site.See study design
What are the potential side effects?
While not explicitly listed, potential side effects may include allergic reactions to ingredients in SurgX gel or skin irritation at the application site. Standard care side effects depend on the typical treatments used post-surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a hip or knee replacement surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks after index procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after index procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Surgical site complication
Secondary outcome measures
Wound images

Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention
The treatment group will receive SurgX™ Antimicrobial Wound Gel™ applied over incision after closure and then re-applied at first dressing change on day of discharge in addition to standard of care.
Group II: Control GroupExperimental Treatment1 Intervention
The control group will receive standard of care.

Find a Location

Who is running the clinical trial?

Next ScienceUNKNOWN
1 Previous Clinical Trials
936 Total Patients Enrolled
Next Science TMIndustry Sponsor
15 Previous Clinical Trials
8,824 Total Patients Enrolled
Northwell HealthLead Sponsor
456 Previous Clinical Trials
469,485 Total Patients Enrolled

Media Library

SurgX Antimicrobial Wound Gel (Antimicrobial Agent) Clinical Trial Eligibility Overview. Trial Name: NCT05517278 — N/A
Total Hip Replacement Research Study Groups: Treatment Group, Control Group
Total Hip Replacement Clinical Trial 2023: SurgX Antimicrobial Wound Gel Highlights & Side Effects. Trial Name: NCT05517278 — N/A
SurgX Antimicrobial Wound Gel (Antimicrobial Agent) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05517278 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are involved in this clinical trial?

"Affirmative. According to clinicaltrials.gov, this research endeavour is presently enlisting volunteers; the initial posting date was September 19th 2022, and it has been amended as recently as September 28th 2022. At present, 700 people are required between 3 different medical centres."

Answered by AI

Is this research collaboration still open to prospective participants?

"Indeed, clinicaltrials.gov indicates that this research-based endeavour is actively recruiting participants. The trial was initially posted on September 19th 2020 and was last updated on the 28th of the same month. At this time, 700 individuals are needed from 3 distinct sites for enrolment into the study."

Answered by AI
Recent research and studies
~467 spots leftby Dec 2024